Kramer et al. provide the first genome-level exploration into the secondary metabolite potential of the Hyphodiscus fungal genus and discover a novel, light-induced metabolite, hyphodiscorubrin. The researchers demonstrate that the natural product potential of filamentous fungi can be much greater than the bioactivity captured during analysis of extracts grown in standard laboratory conditions.